CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
5.94
+0.11 (1.89%)
At close: Aug 24, 2026, 4:00 PM EDT
5.46
-0.48 (-8.15%)
After-hours: Aug 24, 2026, 6:01 PM EDT
CNS Pharmaceuticals Employees
CNS Pharmaceuticals had 8 employees as of December 31, 2025. The number of employees increased by 3 or 60.00% compared to the previous year.
Employees
8
Change (1Y)
3
Growth (1Y)
60.00%
Revenue / Employee
n/a
Profits / Employee
-$2,087,446
Market Cap
8.68M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 8 | 3 | 60.00% | 8 | 0 |
| Dec 31, 2024 | 5 | 0 | - | 4 | 1 |
| Dec 31, 2023 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2022 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2021 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Imunon | 20 |
| FibroBiologics | 15 |
| Soligenix | 14 |
| Aprea Therapeutics | 8 |
| AEON Biopharma | 8 |
| Immuron | 7 |
| Traws Pharma | 7 |
| Ernexa Therapeutics | 7 |
CNSP News
- 3 days ago - CNS Pharmaceuticals Proxy statement: Proxy filing - Filings
- 7 days ago - CNS Pharmaceuticals Slides: Investor presentation - Filings
- 7 days ago - CNS Pharmaceuticals reports Q2 EPS (37c) vs. ($6.42) last year - TheFly
- 7 days ago - CNS Pharmaceuticals ‘actively evaluating’ business devlopment opportunities - TheFly
- 7 days ago - CNS Pharmaceuticals sees cash runway ‘beyond’ twelve months - TheFly
- 12 days ago - CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation - Accesswire
- 12 days ago - CNS Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 12 days ago - CNS Pharmaceuticals Earnings release: Q2 2026 - Filings